LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Kodu・Aktsiate loetelu・Palatin Technologies Inc

Palatin Technologies Inc

Suletud

0.09 -43.75

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.09

Max

0.09

Põhinäitajad
By Trading Economics
Töötajad	30

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+6900% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	14. mai 2025

Turustatistika
By TradingEconomics
Turukapital	5M
Eelmine avamishind	43.84
Eelmine sulgemishind	0.09

Palatin Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. mai 2025, 23:48 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11. mai 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11. mai 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11. mai 2025, 23:38 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Aristocrat Has Significant Firepower for M&A -- Market Talk

11. mai 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11. mai 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11. mai 2025, 23:33 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11. mai 2025, 23:32 UTC

Peamised uudised

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11. mai 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11. mai 2025, 22:33 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11. mai 2025, 20:19 UTC

Peamised uudised

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11. mai 2025, 16:00 UTC

Peamised uudised

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11. mai 2025, 11:00 UTC

Peamised uudised

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11. mai 2025, 08:00 UTC

Peamised uudised

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11. mai 2025, 01:00 UTC

Peamised uudised

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11. mai 2025, 01:00 UTC

Peamised uudised

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10. mai 2025, 21:54 UTC

Peamised uudised

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10. mai 2025, 17:12 UTC

Peamised uudised

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10. mai 2025, 15:41 UTC

Peamised uudised

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10. mai 2025, 12:00 UTC

Peamised uudised

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10. mai 2025, 09:30 UTC

Peamised uudised

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10. mai 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10. mai 2025, 03:52 UTC

Peamised uudised

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9. mai 2025, 23:51 UTC

Omandamised, ülevõtmised, äriostud

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9. mai 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9. mai 2025, 21:37 UTC

Peamised uudised

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9. mai 2025, 21:10 UTC

Peamised uudised

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9. mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. mai 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9. mai 2025, 20:42 UTC

Peamised uudised

Stocks Get a Break From Trade Chaos -- WSJ

Võrdlus sarnastega

Hinnamuutus

Palatin Technologies Inc Prognoos

Hinnasiht

By TipRanks

6900% tõus

12 kuu keskmine prognoos

Keskmine 7 USD 6900%

Kõrge 7 USD

Madal 7 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Palatin Technologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Palatin Technologies Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Palatin Technologies Inc

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.